Recent Security Class Actions

Novo Nordisk A/S Common Stock (NYSE: NVO)

Company Name:Novo Nordisk A/S Common Stock
Stock Symbol:NYSE: NVO
Class Period Start:04/30/2015
Class Period End (inclusive):10/27/2016

According to the law firm press release, the Complaint alleges that during the Class Period, Novo Nordisk reported materially false and misleading earnings and forecasts in that they were inflated through the collusive price fixing of the Company’s insulin drugs. The Complaint also alleges that Novo Nordisk misrepresented and concealed the true extent of the pricing pressures it was experiencing from pharmacy benefit managers.